Si-han X. Chen

Nanchong, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Interleukin-4 promotes the clearance of amyloid-β by monocyte through enhancing the recognition and intracellular processing of amyloid-β.

Interleukin-4 promotes the clearance of amyloid-β by monocyte through enhancing the recognition and intracellular processing of amyloid-β.

Journal: Journal of Alzheimer's disease : JAD

Published: December 11, 2024

Rejuvenation of peripheral immune cells attenuates Alzheimer's disease-like pathologies and behavioral deficits in a mouse model.

Rejuvenation of peripheral immune cells attenuates Alzheimer's disease-like pathologies and behavioral deficits in a mouse model.

Journal: Science advances

Published: May 29, 2024

Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer's disease.

Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer's disease.

Journal: Acta neuropathologica

Published: January 09, 2023

Elevated Levels of Naturally-Occurring Autoantibodies Against the Extracellular Domain of p75NTR Aggravate the Pathology of Alzheimer's Disease.

Elevated Levels of Naturally-Occurring Autoantibodies Against the Extracellular Domain of p75NTR Aggravate the Pathology of Alzheimer's Disease.

Journal: Neuroscience bulletin

Published: March 01, 2022

Polysaccharide Krestin Prevents Alzheimer's Disease-type Pathology and Cognitive Deficits by Enhancing Monocyte Amyloid-β Processing.

Polysaccharide Krestin Prevents Alzheimer's Disease-type Pathology and Cognitive Deficits by Enhancing Monocyte Amyloid-β Processing.

Journal: Neuroscience bulletin

Published: April 02, 2021

Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer's disease.

Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer's disease.

Journal: Molecular psychiatry

Published: October 13, 2020

Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer's disease.

Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer's disease.

Journal: Translational psychiatry

Published: July 17, 2020

Blood cell-produced amyloid-β induces cerebral Alzheimer-type pathologies and behavioral deficits.

Blood cell-produced amyloid-β induces cerebral Alzheimer-type pathologies and behavioral deficits.

Journal: Molecular psychiatry

Published: March 03, 2020

Altered peripheral profile of blood cells in Alzheimer disease: A hospital-based case-control study.

Altered peripheral profile of blood cells in Alzheimer disease: A hospital-based case-control study.

Journal: Medicine

Published: May 25, 2017

Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model.

Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model.

Journal: Acta neuropathologica

Published: February 11, 2017

Heterozygosities and genetic relationship of tea cultivars revealed by simple sequence repeat markers and implications for breeding and genetic mapping programs.

Heterozygosities and genetic relationship of tea cultivars revealed by simple sequence repeat markers and implications for breeding and genetic mapping programs.

Journal: Genetics and molecular research : GMR

Published: April 14, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026